IRIS
BEDINI, ANNALIDA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 8.122
EU - Europa 5.564
AS - Asia 2.192
AF - Africa 25
Continente sconosciuto - Info sul continente non disponibili 22
SA - Sud America 16
OC - Oceania 10
AN - Antartide 1
Totale 15.952
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.073
GB - Regno Unito 2.071
CN - Cina 1.452
IT - Italia 981
UA - Ucraina 888
SE - Svezia 511
TR - Turchia 355
FI - Finlandia 333
DE - Germania 274
SG - Singapore 232
IE - Irlanda 190
FR - Francia 78
RU - Federazione Russa 61
IN - India 59
CA - Canada 46
BE - Belgio 42
NL - Olanda 36
KR - Corea 27
EU - Europa 18
RO - Romania 18
ES - Italia 17
VN - Vietnam 15
JP - Giappone 14
KE - Kenya 11
HK - Hong Kong 10
PL - Polonia 10
CH - Svizzera 9
AL - Albania 8
AU - Australia 8
EG - Egitto 7
BR - Brasile 6
A2 - ???statistics.table.value.countryCode.A2??? 4
AT - Austria 4
DK - Danimarca 4
IR - Iran 4
PK - Pakistan 4
SI - Slovenia 4
TG - Togo 4
AM - Armenia 3
BD - Bangladesh 3
BG - Bulgaria 3
EE - Estonia 3
GR - Grecia 3
HU - Ungheria 3
ID - Indonesia 3
IL - Israele 3
LU - Lussemburgo 3
PE - Perù 3
SA - Arabia Saudita 3
BO - Bolivia 2
CZ - Repubblica Ceca 2
GU - Guam 2
IQ - Iraq 2
SM - San Marino 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
CL - Cile 1
CO - Colombia 1
FK - Isole Falkland (Malvinas) 1
GS - Georgia del Sud e Isole Sandwich Australi 1
HR - Croazia 1
IM - Isola di Man 1
IS - Islanda 1
JM - Giamaica 1
LA - Repubblica Popolare Democratica del Laos 1
MA - Marocco 1
MX - Messico 1
PA - Panama 1
PT - Portogallo 1
PY - Paraguay 1
RS - Serbia 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 15.952
Salva come PNG Salva come JPEG
Città #
Southend 1.893
Woodbridge 1.169
Fairfield 968
Houston 747
Jacksonville 710
Ann Arbor 677
Chandler 588
Ashburn 458
Cambridge 446
Seattle 378
Wilmington 376
Nanjing 351
Urbino 260
Izmir 257
Dublin 188
Boardman 187
Singapore 179
Nanchang 152
Helsinki 138
San Mateo 113
Beijing 109
Princeton 106
Shenyang 83
New York 80
Hebei 78
Changsha 73
Tianjin 71
Düsseldorf 70
Istanbul 62
Jiaxing 56
Kunming 43
Brussels 41
Des Moines 41
Jinan 38
Velikiy Novgorod 38
Bremen 35
Shanghai 35
Venice 30
Guangzhou 28
Toronto 28
San Diego 27
Hangzhou 26
San Francisco 26
London 25
Santa Clara 25
Seongnam 24
Zhengzhou 23
Ningbo 22
Mülheim 20
Haikou 19
Los Angeles 18
Munich 18
Wuppertal 18
Amsterdam 17
Tavullia 17
Milan 16
Rome 16
Changchun 15
Parma 15
Bologna 14
Lanzhou 14
Norwalk 13
Taizhou 12
Auburn Hills 11
Augusta 11
Monte Porzio 11
Dong Ket 10
Leawood 10
Mcallen 10
Redwood City 10
Dearborn 9
Orange 9
Frankfurt am Main 8
Scottsdale 8
Shenzhen 8
West Jordan 8
Acquasanta Terme 7
Ascoli Piceno 7
Fuzhou 7
Madrid 7
Nairobi 7
Osimo 7
Portland 7
Prescot 7
Tirana 7
Acton 6
Ancona 6
Focsani 6
Timisoara 6
Borås 5
Fano 5
Jesi 5
Kiev 5
Kilburn 5
Macerata 5
Monmouth Junction 5
Mumbai 5
Naples 5
Angri 4
Calgary 4
Totale 12.083
Salva come PNG Salva come JPEG
Nome #
1-AMINOCYCLOPROPANE-1-CARBOXYLIC ACID DERIVATIVES AS LIGANDS AT THE GLYCINE-BINDING SITE OF THE N-METHYL-D-ASPARTATE RECEPTOR 329
Iridium-Catalyzed Direct Synthesis of Tryptamine Derivatives from Indoles: Exploiting N-Protected β-Amino Alcohols as Alkylating Agents 319
1-Aminocyclopropane-1-carboxylic acid derivatives as ligands at the glicine-site of the NMDA receptor. 316
1-Aminocyclopropane-1-carboxylic acid derivatives: Synthesis and NMDA receptor complex binding affinity study. 260
Synthesis of Tryptamine Derivatives via a Direct, One-Pot Reductive Alkylation of Indoles 247
Towards the development of 5-HT7 ligands combining serotonin-like and arylpiperazine moieties 239
An improved synthesis of cis-4-phenyl-2-propionamidotetralin (4-P-PDOT): a selective MT2 melatonin receptor antagonist. 234
1-Amminocyclopropane-1-Carboxylic Acid Derivatives: A New, General Synthesis and NMDA Receptor Complex Binding Affiniy Study 233
Therapeutic uses of melatonin and melatonin derivatives: a patent review (2012-2014) 229
Antidepressant-like activity and cardioprotective effects of fatty acid amide hydrolase inhibitor URB694 in socially stressed Wistar Kyoto rats 229
Tricyclic Alkylamides as Melatonin Receptor Ligands with Antagonist or Inverse Agonist Activity 227
Direct, One-Pot Reductive Alkylation of Anilines with Functionalized Acetals Mediated by Triethylsilane and TFA. Straightforward Route for Unsymmetrically Substituted Ethylenediamine 222
Synthesis and Configuration Determination of All Enantiopure Stereoisomers of the Melatonin Receptor Ligand 4-Phenyl-2-propionamidotetralin using an Expedient Optical Resolution of 4-Phenyl-2-tetralone 222
Synthesis and Characterization of New Bivalent Agents as Melatonin- and Histamine H3-Ligands 216
Synthesis and Biological Activity of new melatonin dimeric derivatives. 209
Tetrahydroquinoline Ring as a Versatile Bioisostere of Tetralin for Melatonin Receptor Ligands 208
(E)-3-(2-(N-phenylcarbamoyl)vinyl)pyrrole-2-carboxylic acid derivatives. A novel class of glycine site antagonists. 205
Design, synthesis and biological activity of hydrogen peroxide responsive arylboronate melatonin hybrids 201
4,5-Dihydroisoxazole and 4,5-dihydro-1,2,4-oxadiazole derivatives from cycloaddition reactions of nitrile oxides to alkyl N-(diphenylmethylene)-α ,β -dehydroamino acids 198
An improved route to cycloalka[b]pyrrole 2-carboxylates 195
3-(2-Carbamoylvinyl)-4,5-dimethylpyrrole-2-carboxylic acids as ligands at the NMDA glycine-binding site: a study on the 2-carbamoylvinyl chain modification 195
Highly Potent and Selective MT2 Melatonin Receptor Full Agonists from Conformational Analysis of 1-Benzyl-2-acylaminomethyl-tetrahydroquinolines 192
Synthetic Melatonin Receptor Ligands 189
Toward the Definition of Stereochemical Requirements for MT(2)-Selective Antagonists and Partial Agonists by Studying 4-Phenyl-2-propionamidotetralin Derivatives 189
The rationale for the development of melatonin receptor ligands 187
N-(Anilinoethyl)amides: design and synthesis of metabolically stable, selective melatonin receptor ligands. 185
Pharmacokinetic and pharmacodynamic evaluation of ramelteon : an insomnia therapy 181
Differentiation between isomeric 1-aminocyclopropane-1-carboxylic acid derivatives by means of chemical ionisation and mass selected collision induced dissociation 179
Plant-derived phenolic compounds prevent the DNA single-strand breakage and cytotoxicity induced by tert-butylhydroperoxide via an iron-chelating mechanism. 179
Promotion of non-rapid eye movement sleep and activation of reticular thalamic neurons by a novel MT2 melatonin receptor ligand 178
Cardioprotective effects of fatty acid amide hydrolase inhibitor URB694, in a rodent model of trait anxiety 176
Identification of Bivalent Ligands with Melatonin Receptor Agonist and Fatty Acid Amide Hydrolase (FAAH) Inhibitory Activity That Exhibit Ocular Hypotensive Effect in the Rabbit 172
Substituent effects on 1,3-dipolar cycloadditions to some 1,1-diphenyl-2-aza-1,3-butadiene derivatives 171
Synthesis, Enantiomeric Resolution and Structure-Activity Relationship Study for a Series of 10,11-Dihydro-5H-dibenzo[a,d]cycloheptene MT2 Receptor Antagonists. 170
MELATONIN RECEPTOR AGONISTS: SAR AND APPLICATIONS TO THE TREATMENT OF SLEEP-WAKE DISORDERS 168
Diastereo- and enantioselective hydrogenation of a challenging enamide derived from 4-phenyl-2-tetralone: an appealing shortcut towards enantiopure cis-2-aminotetraline derivatives 168
Melatonin MT1 and MT2 Receptors Exhibit Distinct Effects in the Modulation of Body Temperature across the Light/Dark Cycle 167
Application of 3D-QSAR in the Rational Design of Receptor Ligands and Enzyme Inhibitors 166
2,3-Dehydroamino acid derivatives as intermediates in the synthesis of heterocyclic compounds. 162
Selective Melatonin MT2 receptor ligands relieve neuropathic pain through modulation of brainstem descending antinociceptive pathways 161
Design and synthesis of N-[3,3-diphenyl-propenyl]alkanamides as a novel class of potent MT2-selective Melatonin receptor ligands 160
Bivalent Ligand Approach on N-[2-[(3-methoxyphenyl)methylamino]ethyl]acetamide. Synthesis, Binding Affinity and Intrinsic Acivity for MT(1) and MT(2) melatonin Receptors. 158
2-[N-Acylamino(C1-C3)alkyl]indoles as MT1 melatonin receptor partial agonists, antagonists, and putative inverse agonists 157
Antiproliferative and pro-apoptotic activity of melatonin analogues on melanoma and breast cancer cells 156
Recent advances in the development of melatonin MT1 and MT2 receptor agonists 153
Synthesis and conformational study of 3,4-carbocyclic bridged indole melatonin and serotonin analogues 153
N-Acyl-5- and -2,5-substituted tryptamines: synthesis, activity and affinity for human mt1 and MT2 melatonin receptors 152
Application of a non-electrophysiological method to study binding affinity and efficacy of glicine analogs to the glicine site of the NMDA receptor-ion channel complex. 152
Alchilammidi tricicliche: legandi selettivi dei recettori melatoninergici MT1 e MT2 150
THREE-DIMENSIONAL QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP STUDIES ON SELECTED MT1 AND MT2 MELATONIN RECEPTOR LIGANDS: REQUIREMENTS FOR SUBTYPE SELECTIVITY AND INTRINSIC ACTIVITY MODULATION 149
N-(Substituted-anilinoethyl)acylamides: Design, Synthesis and Pharmacological Characterization of a New Class of Melatonin Receptor Ligands 149
N-acetiltriptamine 2,5-sostituite: sintesi e valutazione dell’attività biologica per i recettori melatoninergici MT1 e MT2 149
Anxiolytic effects of the melatonin MT2 receptor partial agonist UCM765: Comparison with melatonin and diazepam 149
Homology models of melatonin receptors: challenges and recent advances 149
Reactions of 3-Carbomethoxy-2-aza-1,3-Butadiene Derivatives with Dienophiles 148
Strategies leading to MT2 selective melatonin receptor antagonists 148
Strategies leading to MT2 selective melatonin receptor antagonists 147
Melatonin receptor agonists: new options for insomnia and depression treatment 146
(E)-3-[2-(Carbamoylvinyl)]pyrrol-2-carboxylic acid derivatives: A novel Class of glycine site Antagonists. 143
Progettazione e Sintesi di nuovi ligandi dei recettori MT1 e MT2 della melatonina a struttura difenilalchilammidica. 143
Analysis of structure-activity relationships for MT2 selective antagonists by melatonin MT1 and MT2 receptor models 142
Short synthesis of tryptophan and β -carboline derivatives by reaction of indoles with N-(diphenylmethylene)-α ,β -didehydroamino acid esters 139
Synthesis, antioxidant activity and structure-activity relationships for a new series of 2-(N-acylaminoethyl)indoles with melatonin-like cytoprotective activity 136
Synthesis and biological evaluation of 6-bromo-6-substituted penicillanic acid derivatives as beta-lactamase inhibitors. 131
Melatonin, non-selective MT1/MT2 and selective MT2 receptor agonists: differential effects on the 24-hr vigilance states 131
SYNTHESIS, BINDING AFFINITY FOR THE MELATONIN RECEPTOR, AND EVALUATION OF THE BIOLOGICAL ACTIVITY OF NEW INDOLE-BASED MELATONIN ANALOGUES. 130
Synthesis, Pharmacological Characterization and QSAR Studies on 2-Substituted Indole Melatonin Receptor Ligands 129
Indole-based analogs of melatonin: in vitro antioxidant and cytoprotective activities 128
Towards the development of mixed MT1-agonist/MT2-antagonist melatonin receptor ligands 127
ANTIMETASTATIC ACTION OF A NEW ANALOG OF DACARBAZINE IN MICE BEARING LEWIS LUNG CARCINOMA 126
MT2 selective melatonin receptor antagonists. Design and structure activity relationships 124
N-(anilinoethyl)acylamides: new melatonin receptor ligands with sleep inducing properties. 123
A novel melatonin partial agonist with sleep-promoting properties 120
Synthesis of new 6-bromopenicillanic acid derivatives as potential β-lactamase inhibitors. 118
MT2 selective melatonin receptor antagonists: design and structure-activity relationships 118
Antioxidant and cytoprotective activity of indole derivatives related to melatonin, 117
Correlation of the antimetastatic properties of aryltriazenes with their Electron Impact Ionization Mass Spectronomy 113
MT1-Selective Melatonin Receptor Ligands: Synthesis, Pharmacological Evaluation, and Molecular Dynamics Investigation of N-{[(3-O-Substituted)anilino]alkyl}amides 112
Synthesis of new C-6 alkylidene penicillin derivatives as beta-lactamase inhibitors 109
A novel melatonin partial agonist with sleep promoting properties and anti-anxiety effects. 106
INVESTIGATION OF SOME 2,3-DIDEHYDRO AMINOACIFS BY FAST ATOM BOMBARDMENT, CHEMICAL IONIZATION AND MASS-SELECTED COLLISION-INDUCED DISSOCIATION MASS SPECTROMETRY. 105
Analoghi della melatonina: effetto dei sostituenti sull’attività di derivati N-acetiltriptaminici. 104
Selective increase of Slow Wave Sleep (SWS) by a novel melatonin partial agonist 104
In vitro metabolism of the melatonin MT2-receptor selective ligand UCM765 by rat, mouse and human liver substrates 104
Synthesis, binding and QSAR studies of new 2-substituted melatonergic agonists. 104
Rapid and transient stimulation of intracellular reactive oxygen species by melatonin in normal tumor leukocytes, Toxicology and apllied Pharmacology, 239(1), 37-45 (2009) 100
A novel melatonin partial agonist with sleep-promoting properties. 99
Synthesis of new 6-alkyliden penicillin derivatives as potential beta-lactamase inhibitors. 97
Selective increase of Slow Wave Sleep (SWS) by melatonin 2 receptors. 96
2-5-Disubstituted tryptamines a selective serotonin 5HT6 receptor agonists. 92
Novel melatonin ligands having antidepressant activity as well as sleep inducine properties 91
Antioxidant and cytoprotective effect of indole derivatives related to melatonin 90
STRUCTURAL CHARACTERIZATION OF ISOMERIC DIDEHYDRO AMINOACIDS USING CHEMIAL IONIZATION 89
Design and structure-activity relationships of subtype selective melatonin receptor ligands. 88
2-Arylmelatonin analogues: Probing the 2-phenyl binding pocket of melatonin MT1 and MT2 receptors 83
Relazioni struttura attività per analoghi indolici della melatonina ad azione antiossidante e citoprotettiva 83
In vitro evaluation of antioxidant activity for a series of 2-acylaminoethylindoles, PBA2004 83
Design and synthesis of metabolically protected melatonin receptor agonists 78
Razionalizzazione dell’attività di antagonisti MT2 selettivi mediante docking e dinamica molecolare in modelli dei recettori MT1 e MT2 della melatonina. 77
Novel anti-anxiety and sleep-promoting melatonin receptor ligands from modulation of N-anilinoethylamide structure. 75
Totale 15.605
Salva come PNG Salva come JPEG
Categoria #
all - tutte 54.856
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.856
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.564 0 0 0 0 154 278 283 258 169 211 87 124
2020/20211.989 61 137 81 267 108 135 119 156 326 225 255 119
2021/20221.284 128 145 125 165 23 35 57 62 86 72 31 355
2022/20231.850 209 122 56 207 163 405 7 165 296 56 122 42
2023/2024565 32 58 28 77 40 100 32 13 67 57 18 43
2024/2025822 136 105 428 110 43 0 0 0 0 0 0 0
Totale 16.198